Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4T study
2004-000514-38Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jun 2004
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in type 2 diabetes mellitus (T2DM) comparing Levemir arm, NovoMix 30 arm and NovoRapid arm (3 arms). Primary endpoints: HbA1c at 12 months and HbA1c at 36 months. Started Jun 2004; status: completed.
02
Drugs
insulin detemirbiphasic insulin aspartinsulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2004-000514-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000514-38.